Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Observation × 1 year × Clear all

Phase

Phase 3 23 Phase 2 19 Phase NA 3 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 20 pembrolizumab 13 Specimen Handling 13 Radiotherapy 13 Nivolumab 12 Cyclophosphamide 9 Fluorodeoxyglucose F18 8 Biopsy 8 X-Rays 7 fludarabine 6 Bevacizumab 6 venetoclax 5 Radiation 5 Metformin 5 Ipilimumab 5 Etoposide 5 Dexamethasone 5 olaparib 4 fluciclovine F-18 4 Temozolomide 4 Standard of Care 4 Rituximab 4 Paclitaxel 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Doxorubicin 4 Cisplatin 4 tislelizumab 3 gallium 68 PSMA-11 3 encorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡